Korify Capital

About The Fund

Korify Capital is an investment fund that operates with a focus on burgeoning technologies and emerging companies within the BioTech, FinTech, Blockchain, and Cryptos industries. They position themselves as backers of breakthrough technologies particularly in the realms of longevity and mental health, aiming at enabling people to lead long, healthy, and fulfilled lives. Their investment philosophy is to form a portfolio by investing in pioneering companies that redefine these sectors. They support unique approaches led by inventive teams, investing mostly in Series A to Series C funding rounds for companies that have demonstrated strong traction, achieved proof of concept, and are potential future leaders in their fields. Korify Capital's investment range typically lies between $100,000 to $5,000,000, with a sweet spot of around $1,500,000 for their contributions. They focus on various developmental stages of companies, offering seed through to Series B investments. The fund's specialties include pre-seed and seed funding, indicating a propensity to assist in the earliest phases of startup development. Korify Capital's portfolio showcases their commitment to transforming healthcare with investments in companies like Alto, pioneering precision medicine for the brain; Cambrian, creating therapeutics to extend healthspan; and Refoxy, focusing on FOXO modulators to improve longevity and treat age-related diseases. These companies are examples of the fund's commitment to extending the period of life spent in good health through innovative medical approaches. Investors interested in the intersection of technology and healthcare, along with those who share a vision of enhancing the quality and longevity of life, may find alignment with Korify Capital's strategic investment thesis.